Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study

References

• International Diabetes Federation. IDF Diabetes Atlas. 9th ed. International Diabetes Federation; 2019.
   Google Scholar
• Robert AA, Al Dawish MA. Cardiovascular disease among patients with diabetes: the current scenario in Saudi Arabia. Curr Diabetes Rev. 2021;17:180–185. doi:10.2174/1573399816666200527135512
   PubMed Web of Science ®Google Scholar
• El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: challenges and call for action. World J Diabetes. 2021;12:1401. doi:10.4239/wjd.v12.i9.1401
   PubMed Web of Science ®Google Scholar
• Damaskos C, Garmpis N, Kollia P, et al. Assessing cardiovascular risk in patients with diabetes: an update. Curr Cardiol Rev. 2020;16:266–274. doi:10.2174/1573403X15666191111123622
   PubMed Web of Science ®Google Scholar
• Lam T, Burns K, Dennis M, Cheung NW, Gunton JE. Assessment of cardiovascular risk in diabetes: risk scores and provocative testing. World J Diabetes. 2015;6:634. doi:10.4239/wjd.v6.i4.634
   PubMedGoogle Scholar
• Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234. doi:10.1056/NEJM199807233390404
   PubMed Web of Science ®Google Scholar
• Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145:e722–e759. doi:10.1161/cir.0000000000001040
   PubMed Web of Science ®Google Scholar
• Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis. Diabetic Med. 2009;26:142–148. doi:10.1111/j.1464-5491.2008.02640.x
   PubMed Web of Science ®Google Scholar
• Howard BV, Best LG, Galloway JM, et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care. 2006;29:391–397. doi:10.2337/diacare.29.02.06.dc05-1299
   PubMed Web of Science ®Google Scholar
• Wong ND, Glovaci D, Wong K, et al. Global cardiovascular disease risk assessment in United States adults with diabetes. Diabetes Vasc Dis Res. 2012;9:146–152. doi:10.1177/1479164112436403
   PubMed Web of Science ®Google Scholar
• Committee:, A.D.A.P.P. 10. Cardiovascular disease and risk management: standards of medical care in diabetes—2022. Diabetes Care. 2022;45:S144–S174. doi:10.2337/dc22-S010
   PubMed Web of Science ®Google Scholar
• Alzeidan R, Rabiee F, Mandil A, Hersi A, Fayed A, Ali R. Non-communicable disease risk factors among employees and their families of a Saudi university: an epidemiological study. PLoS One. 2016;11(11):e0165036. doi:10.1371/journal.pone.0165036
   PubMed Web of Science ®Google Scholar
• Fayed A, Alzeidan R, Esmaeil S, et al. Cardiovascular risk among Saudi Adults with prediabetes: a sub-cohort analysis from the Heart Health Promotion (HHP) study. Int J Gen Med. 2022;15:6861–6870. doi:10.2147/IJGM.S374190
   PubMed Web of Science ®Google Scholar
• Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can Fam Physician. 2011;57:417–423. doi:10.1136/bmj.c2197
   PubMed Web of Science ®Google Scholar
• Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes Care. 2021;44:S15–S33.
   PubMed Web of Science ®Google Scholar
• Eriksen M, Mackay J, Ross H. The Tobacco Atlas. Vol. 72. Atlanta, GA: American Cancer Society; 2012.
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al.; The National Heart Lung and Blood Institute Joint National Committee on Prevention, National High blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention Detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572. doi:10.1001/jama.289.19.2560
   PubMed Web of Science ®Google Scholar
• Grundy SM. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr. 2017;9:25. doi:10.1186/s13098-017-0225-1
   PubMed Web of Science ®Google Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:1–19. doi:10.1186/s12933-018-0728-6
   PubMed Web of Science ®Google Scholar
• Zhao Y. Cardiovascular risk assessment and screening in diabetes. Cardiovasc Endocrinol. 2017;6:17. doi:10.1097/XCE.0000000000000115
   PubMedGoogle Scholar
• Mondal R, Ritu RB, Banik PC. Cardiovascular risk assessment among type-2 diabetic subjects in selected areas of Bangladesh: concordance among without cholesterol-based WHO/ISH, Globorisk, and Framingham risk prediction tools. Heliyon. 2021;7:e07728. doi:10.1016/j.heliyon.2021.e07728
   PubMed Web of Science ®Google Scholar
• Al-yafei A, Osman SO, Selim N, Alkubaisi N, Singh R. Assessment of cardiovascular disease risk among Qatari patients with type 2 diabetes mellitus, attending primary health care centers, 2014. Open Diabetes J. 2020;10:1–10.
   Google Scholar
• El Bcheraoui C, Basulaiman M, AlMazroa MA, et al. Fruit and vegetable consumption among adults in Saudi Arabia, 2013. Nutr Diet Suppl. 2015;7:41–49.
   Google Scholar
• El Bcheraoui C, Memish Z, Tuffaha M, Daoud F, Robinson M, Jaber S. Hypercholesterolemia and its associated risk factors-Kingdom of Saudi Arabia, 2013: a National Survey. Biomed Rep. 2014;2:564–679. doi:10.3892/br.2014.265
   PubMedGoogle Scholar
• Al-Nozha MM, Al-Hazzaa HM, Arafah MR, et al. Prevalence of physical activity and inactivity among Saudis aged 30–70 years. Saudi Med J. 2007;28:559–568.
   PubMed Web of Science ®Google Scholar
• Al-Hamdan N, Kutbi A, Choudhry A, Nooh R, Shoukri M, Mujib S; Kingdom of Saudi Arabia, in collaboration with World Health Organization, EMRO. WHO stepwise approach to NCD surveillance country-specific standard report Saudi Arabia. Emerg Infect Dis. 2005;11(9):1456–1457. doi:10.3201/eid1109.050081
   PubMedGoogle Scholar
• Alhabib KF, Batais MA, Almigbal TH, et al. Demographic, behavioral, and cardiovascular disease risk factors in the Saudi population: results from the Prospective Urban Rural Epidemiology study (PURE-Saudi). BMC Public Health. 2020;20:1–14.
   PubMed Web of Science ®Google Scholar
• Al-Quwaidhi A, Pearce M, Critchley J, Sobngwi E, O’flaherty M. Trends and future projections of the prevalence of adult obesity in Saudi Arabia, 1992–2022. East Mediterr Health J. 2014;20(10):589–595.
   PubMed Web of Science ®Google Scholar
• Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898–918. doi:10.1161/CIRCULATIONAHA.106.171016
   PubMed Web of Science ®Google Scholar
• Galaviz KI, Narayan KV, Lobelo F, Weber MB. Lifestyle and the prevention of type 2 diabetes: a status report. Am J Lifestyle Med. 2018;12:4–20.
   PubMed Web of Science ®Google Scholar
• Alwan A. Global status Report on Noncommunicable Diseases 2010. World Health Organization; 2011.
   Google Scholar
• Jung CH, Chung JO, Han K, Ko S-H, Ko KS, Park J-Y. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013). Cardiovasc Diabetol. 2017;16:1–15. doi:10.1186/s12933-016-0482-6
   PubMed Web of Science ®Google Scholar
• Cavan D, Harding J, Linnenkamp U, et al. Diabetes and cardiovascular disease; 2016.
   Google Scholar
• Wong ND, Zhao Y, Patel R, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and Jackson heart study. Diabetes Care. 2016;39:668–676.
   PubMed Web of Science ®Google Scholar
• White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. New Engl J Med. 2013;369(14):1327–1335. doi:10.1056/NEJMoa1305889
   PubMed Web of Science ®Google Scholar
• Giorgino F, Leonardini A, Laviola L. Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. Ann NY Acad Sci. 2013;1281:36–50.
   PubMed Web of Science ®Google Scholar